Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1
Viruses · 01.02.2024 · 16 (2) · 231
DOI: 10.3390/v16020231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 01.02.2024. Verfasst von Bin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China. Hauptthemen laut MEDLINE: Varicellovirus, Herpesviridae Infections, Saponins, Hydrolyzable Tannins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qingdao Agricultural University, Department of Science & Technology of Shandong Province, Shandong Province’s “Double-Hundred Talent Plan.
Abstract (Originalsprache)
In the realm of clinical practice, nucleoside analogs are the prevailing antiviral drugs employed to combat feline herpesvirus-1 (FHV-1) infections. However, these drugs, initially formulated for herpes simplex virus (HSV) infections, operate through a singular mechanism and are susceptible to the emergence of drug resistance. These challenges underscore the imperative to innovate and develop alternative antiviral medications featuring unique mechanisms of action, such as viral entry inhibitors. This research endeavors to address this pressing need. Utilizing Bio-layer interferometry (BLI), we meticulously screened drugs to identify natural compounds exhibiting high binding affinity for the herpesvirus functional protein envelope glycoprotein B (gB). The selected drugs underwent a rigorous assessment to gauge their antiviral activity against feline herpesvirus-1 (FHV-1) and to elucidate their mode of action. Our findings unequivocally demonstrated that Saikosaponin B2, Punicalin, and Punicalagin displayed robust antiviral efficacy against FHV-1 at concentrations devoid of cytotoxicity. Specifically, these compounds, Saikosaponin B2, Punicalin, and Punicalagin, are effective in exerting their antiviral effects in the early stages of viral infection without compromising the integrity of the viral particle. Considering the potency and efficacy exhibited by Saikosaponin B2, Punicalin, and Punicalagin in impeding the early entry of FHV-1, it is foreseeable that their chemical structures will be further explored and developed as promising antiviral agents against FHV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Förderung
- Qingdao Agricultural University
- Department of Science & Technology of Shandong Province
- Shandong Province’s “Double-Hundred Talent Plan
- Horizontal project of Qingdao Agricultural University
Zitieren
APA
Liu, B., Jiao, X. Q., Dong, X. F., Guo, P., Wang, S. B., & Qin, Z. H. (2024). Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1. Viruses, 16(2), 231. https://doi.org/10.3390/v16020231
Vancouver
Liu B, Jiao XQ, Dong XF, Guo P, Wang SB, Qin ZH. Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1. Viruses. 2024;16(2):231. doi:10.3390/v16020231
BibTeX
@article{Liu2024,
author = {Liu, Bin and Jiao, Xiao-Qian and Dong, Xu-Feng and Guo, Pei and Wang, Shu-Bai and Qin, Zhi-Hua},
title = {Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1},
journal = {Viruses},
year = {2024},
volume = {16},
number = {2},
pages = {231},
doi = {10.3390/v16020231}
}
EUVIMED